Pointe Advisory believes in servant leadership at its core tenets. As an elite boutique, we harness the power of original research to elevate client strategies. With over 25 years in the strategic research and advisory space, Pointe employs 40 full-time thought leaders and seasoned industry veterans. With their field experience, advanced degrees and PhDs, and sophisticated analysis, you can be confident that our clients are paired with leaders who have a trove of strategic insight to inform the most vital business decisions under the most strenuous of circumstances.
Kelly Chamberlain Meyer, Ph.D
Dr. Kelly Chamberlain Meyer leads the Pointe Health practice and brings more than 13 years of experience across the life science and biomedical research industries. She leverages extensive clinical and pharmaceutical market expertise to aid leadership at global Fortune 500 organizations and biotech start-ups to clarify decision-making and capital allocation priorities.
Kelly has designed and led pharmaceutical and medical device market assessments, scenario planning exercises, long-term market monitoring programs, as well as customer market research initiatives. She leads a team of scientists and business strategists with deep expertise across therapeutic areas including respiratory, immunology, neuroscience, oncology, hematology, gene therapies and a host of rare diseases.
Prior to Pointe, Kelly led multi-year research engagements as a post-doctoral fellow at the National Institute of Neurological Disorders and Stroke and as a doctoral candidate in Georgetown University’s Interdisciplinary Program in Neuroscience. Her research exploring intracellular energetics in the central nervous system has been published in top-tier, peer-reviewed journals. Kelly’s dissertation was awarded Georgetown University’s prestigious Harold N. Glassman Distinguished Dissertation Award in the Sciences in 2018.
Undergraduate: Bachelor of Science, James Madison University
Doctorate: Doctor of Philosophy, Georgetown University